By Sarah Tofte, medical editor The new medical science on the use of cannabis has begun to catch up with the traditional medical treatment of cannabinoids and the medicinal benefits of them.
As cannabis has been shown to be an effective treatment for many conditions, including nausea, nausea and vomiting, a range of different treatments have been suggested.
In the UK, there are currently two forms of cannabis therapy currently available – the Medical Cannabis Act, which allows for medicinal cannabis use, and the Medical Marijuana Regulations, which have the same effect as the Cannabis Act but are made up of fewer restrictions.
Both are based on a principle called the “three-legged stool”, which means that there are two basic categories of cannabis use – medicinal and non-medicinal.
The medicinal cannabis law currently allows for the use by patients with certain qualifying conditions, such as cancer, Crohn’s disease and epilepsy.
This means that patients with cancer or Crohn´s disease are able to use cannabis for pain relief and for symptom relief.
It also means that people who have cancer can legally use cannabis to treat pain, and those with epilepsy can legally have it used for their symptoms.
However, the medicinal cannabis legislation currently does not include patients with severe conditions, and so does not allow for the treatment of chronic pain, as well as cancer and other severe conditions.
The first law, which has been in force since March 2015, allows for people to use medicinal cannabis if they meet certain criteria, such a they are aged at least 18 years old, have a medical condition or are suffering from chronic pain.
A spokesperson for the Department of Health said: “As part of the changes to the Cannabis (Care) Act introduced in the Autumn Statement in 2017, the government has recognised that the medicinal use of medicinal cannabis is not a treatment for all serious illnesses, and therefore has introduced legislation to enable people to access medicinal cannabis through their GP, with the aim of allowing people with these conditions to access the same medicinal benefits as anyone else.”
This legislation allows people to be eligible to access medical cannabis if the criteria have been met.
“However, they added: “There are still specific conditions in which people are not eligible to receive medical cannabis.
In these cases, patients will be able to access it through the Medicines (Scotland) Scheme if they are on a long-term benefit and are also eligible for other benefits such as free prescriptions and access to a GP.
“The Scottish Government is working with the Scottish Medicines Authority (SNMA) and other stakeholders to ensure the Medicinal Cannabis Scheme remains as fair and balanced as possible.”
However if patients do not meet these conditions, the Medicine (Scotland)-Only Scheme, which does not currently cover those with severe and intractable conditions, will continue to be available.
There are currently no plans to amend the medical cannabis law in the future, and any changes to medical cannabis laws are expected to be made in the coming months.
However there are some medical conditions which are currently being treated with cannabis which could be considered for treatment with medicinal cannabis.
There have been several deaths from cannabis poisoning, such, for example, from using cannabis as a painkiller.
Another example is from people who are suffering epilepsy, who are being prescribed cannabis to alleviate the symptoms of epilepsy.
There is also a growing trend towards prescribing cannabis to people with cancer, and other medical conditions, where there are concerns about its safety and side-effects.
However the use and abuse of cannabis, particularly in conjunction with other substances, is a very complex issue, and while there are many different medical conditions that have been identified as potential treatment options, there is still no consensus on the best medical cannabis practices to follow.
The Department of Education and Skills is working to make recommendations on how to tackle the use, abuse and misuse of cannabis and cannabis products in the UK.
In November, it announced that it had issued guidance on the regulation of cannabis.
This guidance outlines what the UK should do when it comes to regulating cannabis.
It suggests that there should be strict licensing and regulation of the production and sale of cannabis in order to protect the health and safety of people who consume it, and that the use or sale of this substance should be subject to strict controls, and enforcement measures.
The guidance also includes a set of recommendations on the legal status of cannabis products, which include guidance on whether cannabis products should be considered “medicine”, and whether it should be taxed, regulated and taxed accordingly.
The Government has also recently published a report which identifies key areas where there is confusion or uncertainty over the future of cannabis policy.
A Department of Justice spokesperson said:”The Department is currently consulting on the regulatory framework for cannabis, and will provide further guidance in due course.”
There are also reports that the UK could soon introduce legislation which would require doctors to prescribe cannabis as part of their clinical training.
This would allow them to prescribe it as a treatment option to patients who do